152 related articles for article (PubMed ID: 37356684)
1. Inhibitory effect of lactoferrin-coated zinc nanoparticles on SARS-CoV-2 replication and entry along with improvement of lung fibrosis induced in adult male albino rats.
El-Fakharany EM; El-Gendi H; El-Maradny YA; Abu-Serie MM; Abdel-Wahhab KG; Shabana ME; Ashry M
Int J Biol Macromol; 2023 Aug; 245():125552. PubMed ID: 37356684
[TBL] [Abstract][Full Text] [Related]
2. Green synthesis, characterization, anti-SARS-CoV-2 entry, and replication of lactoferrin-coated zinc nanoparticles with halting lung fibrosis induced in adult male albino rats.
El-Fakharany EM; El-Maradny YA; Ashry M; Abdel-Wahhab KG; Shabana ME; El-Gendi H
Sci Rep; 2023 Sep; 13(1):15921. PubMed ID: 37741872
[TBL] [Abstract][Full Text] [Related]
3. The
Hu Y; Meng X; Zhang F; Xiang Y; Wang J
Emerg Microbes Infect; 2021 Dec; 10(1):317-330. PubMed ID: 33560940
[TBL] [Abstract][Full Text] [Related]
4. Chemical and spectroscopic characterization of (Artemisinin/Querctin/ Zinc) novel mixed ligand complex with assessment of its potent high antiviral activity against SARS-CoV-2 and antioxidant capacity against toxicity induced by acrylamide in male rats.
El-Megharbel SM; Qahl SH; Albogami B; Hamza RZ
PeerJ; 2024; 12():e15638. PubMed ID: 38188145
[TBL] [Abstract][Full Text] [Related]
5. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
[TBL] [Abstract][Full Text] [Related]
6. An overview on in vitro and in vivo antiviral activity of lactoferrin: its efficacy against SARS-CoV-2 infection.
Rosa L; Cutone A; Conte MP; Campione E; Bianchi L; Valenti P
Biometals; 2023 Jun; 36(3):417-436. PubMed ID: 35920949
[TBL] [Abstract][Full Text] [Related]
7. Bovine lactoferrin inhibits SARS-CoV-2 and SARS-CoV-1 by targeting the RdRp complex and alleviates viral infection in the hamster model.
He ST; Qin H; Guan L; Liu K; Hong B; Zhang X; Lou F; Li M; Lin W; Chen Y; He C; Liu F; Lu S; Luo S; Zhu S; An X; Song L; Fan H; Tong Y
J Med Virol; 2023 Jan; 95(1):e28281. PubMed ID: 36329614
[TBL] [Abstract][Full Text] [Related]
8. Amuvatinib Blocks SARS-CoV-2 Infection at the Entry Step of the Viral Life Cycle.
Huynh TTX; Pham TX; Lee GH; Lee JB; Lee SG; Tark D; Lim YS; Hwang SB
Microbiol Spectr; 2023 Jun; 11(3):e0510522. PubMed ID: 36995225
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of SARS pseudovirus cell entry by lactoferrin binding to heparan sulfate proteoglycans.
Lang J; Yang N; Deng J; Liu K; Yang P; Zhang G; Jiang C
PLoS One; 2011; 6(8):e23710. PubMed ID: 21887302
[TBL] [Abstract][Full Text] [Related]
10. TGF-β1 Inhibition of ACE2 Mediated by miRNA Uncovers Novel Mechanism of SARS-CoV-2 Pathogenesis.
Hejenkowska ED; Mitash N; Donovan JE; Chandra A; Bertrand C; De Santi C; Greene CM; Mu F; Swiatecka-Urban A
J Innate Immun; 2023; 15(1):629-646. PubMed ID: 37579743
[TBL] [Abstract][Full Text] [Related]
11. Molecular mimicry of the receptor-binding domain of the SARS-CoV-2 spike protein: from the interaction of spike-specific antibodies with transferrin and lactoferrin to the antiviral effects of human recombinant lactoferrin.
Sokolov AV; Isakova-Sivak IN; Mezhenskaya DA; Kostevich VA; Gorbunov NP; Elizarova AY; Matyushenko VA; Berson YM; Grudinina NA; Kolmakov NN; Zabrodskaya YA; Komlev AS; Semak IV; Budevich AI; Rudenko LG; Vasilyev VB
Biometals; 2023 Jun; 36(3):437-462. PubMed ID: 36334191
[TBL] [Abstract][Full Text] [Related]
12. Protective Effects of Lactoferrin against SARS-CoV-2 Infection In Vitro.
Salaris C; Scarpa M; Elli M; Bertolini A; Guglielmetti S; Pregliasco F; Blandizzi C; Brun P; Castagliuolo I
Nutrients; 2021 Jan; 13(2):. PubMed ID: 33498631
[TBL] [Abstract][Full Text] [Related]
13. The Two-Way Switch Role of ACE2 in the Treatment of Novel Coronavirus Pneumonia and Underlying Comorbidities.
Pang XC; Zhang HX; Zhang Z; Rinkiko S; Cui YM; Zhu YZ
Molecules; 2020 Dec; 26(1):. PubMed ID: 33396184
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy.
Datta PK; Liu F; Fischer T; Rappaport J; Qin X
Theranostics; 2020; 10(16):7448-7464. PubMed ID: 32642005
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic and Therapeutic Potential Zinc Metallodrugs Drug Discovery: Identification of SARS-CoV-2 Replication and Spike/ACE2 Inhibitors.
Ngoepe MP; Tapala KC; Clayton HS
Curr Comput Aided Drug Des; 2022; 18(7):519-534. PubMed ID: 36154578
[TBL] [Abstract][Full Text] [Related]
16. Rationally Designed ACE2-Derived Peptides Inhibit SARS-CoV-2.
Larue RC; Xing E; Kenney AD; Zhang Y; Tuazon JA; Li J; Yount JS; Li PK; Sharma A
Bioconjug Chem; 2021 Jan; 32(1):215-223. PubMed ID: 33356169
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic potential of green tea catechin, (-)-epigallocatechin-3-
Dinda B; Dinda S; Dinda M
Phytomed Plus; 2023 Feb; 3(1):100402. PubMed ID: 36597465
[TBL] [Abstract][Full Text] [Related]
18. Liposomal Lactoferrin Exerts Antiviral Activity against HCoV-229E and SARS-CoV-2 Pseudoviruses In Vitro.
Andreu S; Ripa I; Bello-Morales R; López-Guerrero JA
Viruses; 2023 Apr; 15(4):. PubMed ID: 37112952
[TBL] [Abstract][Full Text] [Related]
19. Development of targeted nanoparticles loaded with antiviral drugs for SARS-CoV-2 inhibition.
Sanna V; Satta S; Hsiai T; Sechi M
Eur J Med Chem; 2022 Mar; 231():114121. PubMed ID: 35114539
[TBL] [Abstract][Full Text] [Related]
20. Shedding Light on the Inhibitory Mechanisms of SARS-CoV-1/CoV-2 Spike Proteins by ACE2-Designed Peptides.
Freitas FC; Ferreira PHB; Favaro DC; Oliveira RJ
J Chem Inf Model; 2021 Mar; 61(3):1226-1243. PubMed ID: 33619962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
